KAIST Identifies Molecular Switch Regulating Cell Growth, Opening New Cancer‑Drug Pathways

Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have discovered a distinct molecular switch that directly controls nutrient‑driven cell‑growth signaling pathways. The switch governs how cells scale proliferation in response to nutrient availability, filling a critical gap in understanding cellular signaling networks.

The finding provides a concrete architectural target for designing next‑generation anticancer therapeutics that could disrupt uncontrolled cell proliferation. By targeting this switch, future drugs may more precisely inhibit tumor growth without affecting normal cells, promising a new direction for cancer drug development.